← Back
$FULC All transactions

Fulcrum Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$45K

Shares

3,452

Price

$13

Filed

Dec 17

Insider

Name

Oltmans Curtis Gale

Title

Chief Legal Officer

CIK

0001714982

Roles

Officer

Transaction Details

Transaction Date

2025-12-15

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

10,252

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 8, 2025. | Includes 10,252 shares that were previously acquired under the Issuer's employee stock purchase plan.

Filing Info

Accession No.

0001193125-25-322740

Form Type

4

Issuer CIK

0001680581

Oltmans Curtis Gale's History

Date Ticker Type Value
2025-12-15 FULC $45K

Other Insiders at FULC (90d)

No other insider activity at this issuer in the last 90 days.